Article: Serum levels of total and urine level of PCA3 in patients with benign prostatic hyperplasia and prostate cancer

Background: Urine test with the PSA result will provide a good prognosis of the prostate cancer. Therefore, considering the importance of PCA3 in this study, we aimed to compare the serum total and urinary PCA3 levels in patients with benign hyperplasia and prostate cancer.

Methods: This cross-sectional study was performed on 90 patients referring to Noor and Hazrat-e-Ali Asghar Hospital in Isfahan from October 2017 to October 2018 for prostate biopsy. Patients were divided into two groups including benign prostate hyperplasia (BPH) and prostate cancer. Serum total and urinary PCA3 levels were measured and compared in both groups.

Results: 38 patients with prostate cancer and 52 patients with BPH participated in this study. Mean age in prostate cancer group was significantly higher than BPH group (P=0.01). Also mean PCA3, and total PSA, in patients with prostate cancer was significantly higher than patients with BPH (P<0.05).

Conclusion: PCA3 was an important marker in patients with prostate cancer and BPH.

Citing Articles

Diagnostic value of total serum/free prostate specific antigen and prostate cancer antigen-3 levels in prostate cancer.

Yazdani M, Saberi N, Baradaran A, Mohajeri Z Am J Clin Exp Urol. 2023; 11(5):414-419.

PMID: 37941653 PMC: 10628628.

Prostate cancer immunotherapy: a review of recent advancements with novel treatment methods and efficacy.

Wang I, Song L, Wang B, Kalebasty A, Uchio E, Zi X Am J Clin Exp Urol. 2022; 10(4):210-233.

PMID: 36051616 PMC: 9428569.

References

1.

Alavi A, Izadpanahi M, Haghshenas L, Faridizad R, Eslami M, Ghadimi K . Comparing urine levels of BLCA-4 nuclear matrix protein in patients with bladder cancer and non-bladder cancer. Int J Physiol Pathophysiol Pharmacol. 2020; 11(6):289-292. PMC: 6971499. View

2.

Auprich M, Bjartell A, Chun F, De La Taille A, Freedland S, Haese A . Contemporary role of prostate cancer antigen 3 in the management of prostate cancer. Eur Urol. 2011; 60(5):1045-54. DOI: 10.1016/j.eururo.2011.08.003. View

3.

Pyo J, Cho W . Systematic review and meta-analysis of prostatic artery embolisation for lower urinary tract symptoms related to benign prostatic hyperplasia. Clin Radiol. 2016; 72(1):16-22. DOI: 10.1016/j.crad.2016.10.009. View

4.

Mikhaylenko D, Perepechin D, Grigoryeva M, Zhinzhilo T, Safronova N, Efremov G . [PCA3 AND TMPRSS2:ERG GENES EXPRESSION IN BIOPSIES OF BENIGN PROSTATE HYPERPLASIA, INTRAEPITHELIAL NEOPLASIA, AND PROSTATE CANCER]. Urologiia. 2016; (5):46-50. View

5.

Ramos C, Valdevenito R, Vergara I, Anabalon P, Sanchez C, Fulla J . PCA3 sensitivity and specificity for prostate cancer detection in patients with abnormal PSA and/or suspicious digital rectal examination. First Latin American experience. Urol Oncol. 2012; 31(8):1522-6. DOI: 10.1016/j.urolonc.2012.05.002. View

6.

Hosseini J, Fallah-Karkan M, Rahavian A, Soleimanzadeh F, Salimi H, Ghadimi K . Feasibility, complication and long-term follow-up of the newly nelaton based urethral dilation method, retrospective study. Am J Clin Exp Urol. 2020; 7(6):378-383. PMC: 6971477. View

7.

Shen M, Chen W, Yu K, Chen Z, Zhou W, Lin X . The diagnostic value of PCA3 gene-based analysis of urine sediments after digital rectal examination for prostate cancer in a Chinese population. Exp Mol Pathol. 2010; 90(1):97-100. DOI: 10.1016/j.yexmp.2010.10.009. View

8.

Bosco C, Garmo H, Adolfsson J, Stattin P, Holmberg L, Nilsson P . Prostate Cancer Radiation Therapy and Risk of Thromboembolic Events. Int J Radiat Oncol Biol Phys. 2017; 97(5):1026-1031. DOI: 10.1016/j.ijrobp.2017.01.218. View

9.

Stephan C, Ralla B, Jung K . Prostate-specific antigen and other serum and urine markers in prostate cancer. Biochim Biophys Acta. 2014; 1846(1):99-112. DOI: 10.1016/j.bbcan.2014.04.001. View

10.

Mlcochova H, Hezova R, Stanik M, Slaby O . Urine microRNAs as potential noninvasive biomarkers in urologic cancers. Urol Oncol. 2013; 32(1):41.e1-9. DOI: 10.1016/j.urolonc.2013.04.011. View

11.

Han Z, Zhang L, Zhu R, Luo L, Zhu M, Fan L . Relationship of oestrogen receptor alpha gene polymorphisms with risk for benign prostatic hyperplasia and prostate cancer in Chinese men. Medicine (Baltimore). 2017; 96(13):e6473. PMC: 5380269. DOI: 10.1097/MD.0000000000006473. View

Serum Levels of Total and Urine Level of PCA3 in Patients with Benign Prostatic Hyperplasia and Prostate Cancer